Atrophoderma: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Atrophoderma | |||
| image = [[File:Steroid_Atrophy_Hands.png|250px]] | |||
| caption = Example of skin atrophy on the hands | |||
| synonyms = Atrophoderma of Pasini and Pierini | |||
| specialty = [[Dermatology]] | |||
| symptoms = Thinning of the skin, loss of skin elasticity | |||
| complications = [[Scleroderma]], [[Morphea]] | |||
| onset = Typically in adolescence or early adulthood | |||
| duration = Chronic | |||
| causes = Unknown, possibly autoimmune | |||
| risks = Family history, [[autoimmune disease]] | |||
| diagnosis = Clinical examination, [[skin biopsy]] | |||
| differential = [[Morphea]], [[Lichen sclerosus]], [[Anetoderma]] | |||
| treatment = [[Topical corticosteroids]], [[Phototherapy]], [[Immunosuppressive drugs]] | |||
| prognosis = Variable, may stabilize or progress | |||
| frequency = Rare | |||
}} | |||
{{DISPLAYTITLE:Atrophoderma}} | {{DISPLAYTITLE:Atrophoderma}} | ||
'''Atrophoderma''' is a term used to describe a group of skin conditions characterized by localized or diffuse thinning of the skin. This condition can result from a variety of causes, including genetic factors, inflammatory processes, or the use of certain medications such as corticosteroids. | '''Atrophoderma''' is a term used to describe a group of skin conditions characterized by localized or diffuse thinning of the skin. This condition can result from a variety of causes, including genetic factors, inflammatory processes, or the use of certain medications such as corticosteroids. | ||
== Etiology == | == Etiology == | ||
Atrophoderma can be classified based on its underlying cause: | Atrophoderma can be classified based on its underlying cause: | ||
* '''[[Atrophoderma of Pasini and Pierini]]''': A form of atrophoderma that presents as hyperpigmented, depressed patches on the skin, often on the trunk. | * '''[[Atrophoderma of Pasini and Pierini]]''': A form of atrophoderma that presents as hyperpigmented, depressed patches on the skin, often on the trunk. | ||
* '''[[Steroid-induced atrophy]]''': Prolonged use of topical or systemic corticosteroids can lead to thinning of the skin, known as steroid atrophy. | * '''[[Steroid-induced atrophy]]''': Prolonged use of topical or systemic corticosteroids can lead to thinning of the skin, known as steroid atrophy. | ||
* '''[[Anetoderma]]''': Characterized by localized areas of slack skin due to loss of elastic tissue. | * '''[[Anetoderma]]''': Characterized by localized areas of slack skin due to loss of elastic tissue. | ||
== Clinical Presentation == | == Clinical Presentation == | ||
The clinical features of atrophoderma vary depending on the specific type and cause. Common features include: | The clinical features of atrophoderma vary depending on the specific type and cause. Common features include: | ||
* Thinning of the skin | * Thinning of the skin | ||
* Depressed or indented patches | * Depressed or indented patches | ||
* Changes in skin pigmentation | * Changes in skin pigmentation | ||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of atrophoderma is primarily clinical, based on the appearance of the skin. A [[skin biopsy]] may be performed to confirm the diagnosis and rule out other conditions. | Diagnosis of atrophoderma is primarily clinical, based on the appearance of the skin. A [[skin biopsy]] may be performed to confirm the diagnosis and rule out other conditions. | ||
== Management == | == Management == | ||
Management of atrophoderma depends on the underlying cause. For steroid-induced atrophy, discontinuation or reduction of corticosteroid use is recommended. Other treatments may include: | Management of atrophoderma depends on the underlying cause. For steroid-induced atrophy, discontinuation or reduction of corticosteroid use is recommended. Other treatments may include: | ||
* [[Topical retinoids]] | * [[Topical retinoids]] | ||
* [[Laser therapy]] | * [[Laser therapy]] | ||
* [[Phototherapy]] | * [[Phototherapy]] | ||
== Prognosis == | == Prognosis == | ||
The prognosis for atrophoderma varies. Some forms, such as steroid-induced atrophy, may improve with treatment, while others may persist or progress. | The prognosis for atrophoderma varies. Some forms, such as steroid-induced atrophy, may improve with treatment, while others may persist or progress. | ||
== See Also == | |||
== | |||
* [[Dermatology]] | * [[Dermatology]] | ||
* [[Skin atrophy]] | * [[Skin atrophy]] | ||
* [[Corticosteroids]] | * [[Corticosteroids]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Skin conditions]] | [[Category:Skin conditions]] | ||
Latest revision as of 21:58, 5 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Atrophoderma | |
|---|---|
| |
| Synonyms | Atrophoderma of Pasini and Pierini |
| Pronounce | N/A |
| Specialty | Dermatology |
| Symptoms | Thinning of the skin, loss of skin elasticity |
| Complications | Scleroderma, Morphea |
| Onset | Typically in adolescence or early adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Unknown, possibly autoimmune |
| Risks | Family history, autoimmune disease |
| Diagnosis | Clinical examination, skin biopsy |
| Differential diagnosis | Morphea, Lichen sclerosus, Anetoderma |
| Prevention | N/A |
| Treatment | Topical corticosteroids, Phototherapy, Immunosuppressive drugs |
| Medication | N/A |
| Prognosis | Variable, may stabilize or progress |
| Frequency | Rare |
| Deaths | N/A |
Atrophoderma is a term used to describe a group of skin conditions characterized by localized or diffuse thinning of the skin. This condition can result from a variety of causes, including genetic factors, inflammatory processes, or the use of certain medications such as corticosteroids.
Etiology[edit]
Atrophoderma can be classified based on its underlying cause:
- Atrophoderma of Pasini and Pierini: A form of atrophoderma that presents as hyperpigmented, depressed patches on the skin, often on the trunk.
- Steroid-induced atrophy: Prolonged use of topical or systemic corticosteroids can lead to thinning of the skin, known as steroid atrophy.
- Anetoderma: Characterized by localized areas of slack skin due to loss of elastic tissue.
Clinical Presentation[edit]
The clinical features of atrophoderma vary depending on the specific type and cause. Common features include:
- Thinning of the skin
- Depressed or indented patches
- Changes in skin pigmentation
Diagnosis[edit]
Diagnosis of atrophoderma is primarily clinical, based on the appearance of the skin. A skin biopsy may be performed to confirm the diagnosis and rule out other conditions.
Management[edit]
Management of atrophoderma depends on the underlying cause. For steroid-induced atrophy, discontinuation or reduction of corticosteroid use is recommended. Other treatments may include:
Prognosis[edit]
The prognosis for atrophoderma varies. Some forms, such as steroid-induced atrophy, may improve with treatment, while others may persist or progress.
